Do endothelial progenitor cells modify our strategy to treat risk factors?
Главные авторы: | Tousoulis, D, Andreou, I, Antoniades, C, Siasos, G, Stougiannos, P, Trikas, A, Stefanadis, C |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2011
|
Схожие документы
-
Do endothelial progenitor cells modify our strategy to treat risk factors?
по: Tousoulis, D, и др.
Опубликовано: (2010) -
Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
по: Andreou, I, и др.
Опубликовано: (2006) -
Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
по: Tousoulis, D, и др.
Опубликовано: (2008) -
Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.
по: Bakogiannis, C, и др.
Опубликовано: (2012) -
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
по: Briasoulis, A, и др.
Опубликовано: (2011)